Recent evidence has implicated APOBEC3B as a source of mutations in cervical, bladder, lung, head and neck, and breast cancers. APOBEC enzymes normally function in innate immune responses, including those that target retroviruses, suggesting links between mutagenesis, immunity and viral infection in the process of cancer development.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis
BMC Bioinformatics Open Access 02 August 2022
-
Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types
BMC Medical Genomics Open Access 18 September 2019
-
Multiple genetic mutations caused by NKX6.3 depletion contribute to gastric tumorigenesis
Scientific Reports Open Access 04 December 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Burns, M.B., Temiz, N.A. & Harris, R.S. Nat. Genet. 45, 977–983 (2013).
Roberts, S.A., Getz, G. & Gordenin, D.A. Nat. Genet. 45, 970–976 (2013).
Harris, R.S. & Liddament, M.T. Nat. Rev. Immunol. 4, 868–877 (2004).
Burns, M.B. et al. Nature 494, 366–370 (2013).
Lada, A.G. et al. Biol. Direct 7, 47 (2012).
Taylor, B.J. et al. eLife 2, e00534 (2013).
Lawrence, M.S. et al. Nature 499, 214–218 (2013).
Nik-Zainal, S. et al. Cell 149, 979–993 (2012).
Loeb, L.A. & Preston, B.D. Annu. Rev. Genet. 20, 201–230 (1986).
Bishop, K.N. et al. Curr. Biol. 14, 1392–1396 (2004).
Beale, R.C. et al. J. Mol. Biol. 337, 585–596 (2004).
Yamanaka, S. et al. Proc. Natl. Acad. Sci. USA 92, 8483–8487 (1995).
Robbiani, D.F. & Nussenzweig, M.C. Annu. Rev. Pathol. 8, 79–103 (2013).
Matsumoto, Y. et al. Nat. Med. 13, 470–476 (2007).
Prindle, M.J., Fox, E.J. & Loeb, L.A. Curr. Drug Targets 10, 1296–1303 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Source data
Rights and permissions
About this article
Cite this article
Kuong, K., Loeb, L. APOBEC3B mutagenesis in cancer. Nat Genet 45, 964–965 (2013). https://doi.org/10.1038/ng.2736
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2736
This article is cited by
-
Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis
BMC Bioinformatics (2022)
-
Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer
Nature Genetics (2022)
-
Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types
BMC Medical Genomics (2019)
-
Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
Oncogene (2019)
-
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas
Molecular Biology Reports (2019)